| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |